Epoetin Alfa (EPIAO) is indicated for the treatment of: Anemia due to chronic renal failure (CRF), including patients on hemodialysis (HD) or not on dialysis (ND).
Peri-operative patients in order to reduce the need for allogeneic RBC transfusions.
Anemia associated with chemotherapy in cancer patients with non-myeloid malignancies. Epoetin Alfa (EPIAO) is not indicated for the treatment of anemia caused by other factors such as iron or folate deficiencies, hemolysis or gastrointestinal bleeding.
Other Services
Country
Account